Anti-cyclic citrullinated peptide-2 (CCP2) autoantibodies and extra-articular manifestations in Greek patients with rheumatoid arthritis (Q44830835)

From Wikidata

Jump to navigation Jump to search

scientific article published on 3 January 2008

edit

Language	Label	Description	Also known as
English	Anti-cyclic citrullinated peptide-2 (CCP2) autoantibodies and extra-articular manifestations in Greek patients with rheumatoid arthritis	scientific article published on 3 January 2008

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18172572

retrieved

6 December 2017

title

Anti-cyclic citrullinated peptide-2 (CCP2) autoantibodies and extra-articular manifestations in Greek patients with rheumatoid arthritis (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18172572

retrieved

6 December 2017

main subject

autoantibody

1 reference

based on heuristic

inferred from title

author

Anastasios Germenis

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18172572

retrieved

6 December 2017

Lazaros I Sakkas

series ordinal

6

object named as

Lazaros I Sakkas

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18172572

retrieved

6 December 2017

author name string

Ioannis Alexiou

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18172572

retrieved

6 December 2017

Athanasios Koutroumpas

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18172572

retrieved

6 December 2017

Anastasia Kontogianni

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18172572

retrieved

6 December 2017

Katerina Theodoridou

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18172572

retrieved

6 December 2017

publication date

3 January 2008

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18172572

retrieved

6 December 2017

published in

Clinical Rheumatology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18172572

retrieved

6 December 2017

volume

27

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18172572

retrieved

6 December 2017

issue

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18172572

retrieved

6 December 2017

page(s)

511-513

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18172572

retrieved

6 December 2017

cites work

Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS10067-007-0800-1

retrieved

21 January 2018

HLA class II sequence polymorphisms and susceptibility to rheumatoid arthritis in Greeks. The HLA-DR beta shared-epitope hypothesis accounts for the disease in only a minority of Greek patients

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18172572

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HLA-DRB1* genotypes in Greek rheumatoid arthritis patients: association with disease characteristics, sex and age at onset

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18172572

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18172572

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rheumatoid factor and anticitrullinated protein antibodies in rheumatoid arthritis: diagnostic value, associations with radiological progression rate, and extra-articular manifestations

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18172572

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Strong combined gene-environment effects in anti-cyclic citrullinated peptide-positive rheumatoid arthritis: a nationwide case-control study in Denmark

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18172572

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The HLA–DRB1 shared epitope alleles are primarily a risk factor for anti–cyclic citrullinated peptide antibodies and are not an independent risk factor for development of rheumatoid arthritis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18172572

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Factors associated with the development of vasculitis in rheumatoid arthritis: results of a case-control study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18172572

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Decrease of anti-cyclic citrullinated peptide antibodies and rheumatoid factor following anti-TNFalpha therapy (infliximab) in rheumatoid arthritis is associated with clinical improvement

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18172572

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-cyclic citrullinated peptide (CCP) antibodies in patients with long-standing rheumatoid arthritis and their relationship with extra-articular manifestations

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18172572

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use and significance of anti-CCP autoantibodies in rheumatoid arthritis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18172572

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Longitudinal analysis of citrullinated protein/peptide antibodies (anti-CP) during 5 year follow up in early rheumatoid arthritis: anti-CP status predicts worse disease activity and greater radiological progression

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18172572

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18172572

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rheumatoid factor and antibodies to cyclic citrullinated peptides are associated with severe extra-articular manifestations in rheumatoid arthritis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18172572

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Survival in rheumatoid arthritis: a population-based analysis of trends over 40 years

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18172572

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diagnostic value of anti-cyclic citrullinated peptide antibodies in Greek patients with rheumatoid arthritis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18172572

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antibodies against cyclic citrullinated peptides in patients affected by rheumatoid arthritis before and after infliximab treatment

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18172572

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1007/S10067-007-0800-1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18172572

retrieved

6 December 2017

PubMed publication ID

18172572

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18172572

retrieved

6 December 2017

ResearchGate publication ID

5676567

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44830835&oldid=2048809365"